Wound Care Dressings Market report provides details about production, revenue, gross margin, consumption value & volume, sale price, import and export, and forecast to 2022 Learn details of the Economical Impact, Development Trends and Growth Rate (2017-2022) (more…)Read More
NEWPORT NEWS, Va., July 18, 2017 /PRNewswire/ — All four sizes of TheraSkin® are now available to nearly 9 million veterans treated by more than 110 VA Medical Centers and 800 Community Based Outpatient Centers (CBOCs) nationwide as a result of the Department of Veterans Affairs updating their Federal Supply Schedule. (more…)Read More
Ophthalmology is a great specialty partly because procedures, devices and drugs constantly evolve, keeping us learning and giving our patients better care. Ask your colleagues in other specialties, and you’ll find that the pace of change in most other medical fields is not nearly as rapid as in ours.
Over the past few years, this pace of change has been very evident in glaucoma, where minimally invasive procedures have greatly diminished the frequency of trabeculectomy and tube shunt procedures. In this issue of OSN, our cover story focuses on a specialty that’s now moving as quickly as glaucoma. And here are three reasons I believe cornea will continue to be the “next big thing” in eye care: (more…)Read More
The cutting-edge of wound care is a progressively flexible one, where textiles, foams, and films are applied to wound management technology with the goal of synergistic physiological function. These innately intuitive materials underpin the emerging medical solutions that practitioners and their patients are finding more effective than traditional wound care and closure methods. With an aging population more frequently seeking medical care and a surge in diabetes diagnoses, market analysts predict a continuing rise in demand for advanced wound care management products, fueling an annual industry growth rate of 6.4% over the next five years. (more…)Read More
Three registered nurses (RN) at Panhandle Home Health have passed the National Wound Care & Ostomy Certification Course & Exam (WCC) as part of Panhandle Home Health’s Wound Care Initiative, started in 2013 with a single WCC-certified RN, Cathy Reifer. In 2015, WISH (Women Investing in Shepherd) awarded their inaugural grant to a regional nonprofit, Panhandle Home Health. This grant of $26,250, along with additional private donations and grants, has allowed thirteen nurses to participate in the intensive, week-long training course. These RNs are prepared to provide specialized consultation and a unique supervisory level of clinical expertise in wound assessment and the specialized care involved for patients. Their training involves differentiation of wound types and the appropriate care; recognizing the effects of cancer, heart disease, diabetes, or COPD on wound healing; understanding care products and their implementation; wound-healing techniques; and patient education. (more…)Read More
An innovative “Smart Scar-Care” pad which serves the dual functions of reinforcing pressure and occlusion has been designed by researchers to treat hypertrophic scars from burns, surgeries and trauma.
Compared with the traditional pressure pads and silicone gel sheets, “Smart Scar-Care” pad has the advantages of both.
It showed good performance in reducing pigmentation and vascularity, improving elasticity and preventing dehydration in a clinical trial. It is more durable and user-friendly compared with the traditional pad (polyethylene foam) as reported by the patients. This innovative design has won the Grand Award and Gold Medal with the Congratulations of Jury at the 45th International Exhibition of Inventions of Geneva, 2017. (more…)Read More
A 39-year-old woman presents to the ED with leg pain and fever. She initially noted redness and pain above her knee 2 weeks ago and was evaluated at an outside hospital. She completed a 10-day course of oral antibiotics for cellulitis. Over the last two days, she has had progressive leg swelling of her entire right thigh. The pain is now so severe that she is having difficulty walking. Her past medical history is negative for diabetes mellitus, chronic liver disease, or alcohol and IV drug use.
On exam, she is febrile to 102.7 F, heart rate is 96 bpm, and blood pressure is 112/65. She has a 12 cm area of faint erythema on her right thigh and tenderness to palpation of her entire right leg with diffuse edema. There is no ecchymosis or bullae formation. (more…)Read More
MicroRNAs are interesting target structures for new therapeutic agents. They can be blocked through synthetic antimiRs. However, to date it was not possible to use these only locally. Researchers at Goethe University Frankfurt have now successfully achieved this in the treatment of impaired wound healing with the help of light-inducible antimiRs.
MicroRNAs are small gene fragments which bond onto target structures in cells and in this way prevent certain proteins from forming. As they play a key role in the occurrence and manifestation of various diseases, researchers have developed what are known as antimiRs, which block microRNA function. The disadvantage of this approach is, however, that the blockade can lead to side effects throughout the entire body since microRNAs can perform different functions in various organs. Researchers at Goethe University Frankfurt have now solved this problem. (more…)Read More
The FDA-approved skin substitute reduces inflammation and transforms chronic wounds into acute injuries.
Six hours north of Reykjavik, along a narrow road tracing windswept fjords, is the Icelandic town of Isafjordur, home of 3,000 people and the midnight sun. On a blustery May afternoon, snow still fills the couloirs that loom over the docks, where the Pall Palsson, a 583-ton trawler, has just returned from a three-day trip. Below the rust-spotted deck, neat boxes are packed with freshly caught fish and ice. “If you take all the skins from that trawler,” says Fertram Sigurjonsson, the chairman and chief executive officer of Kerecis Ltd., gesturing over the catch, “we would be able to treat one in five wounds in the world.” (more…)Read More
PolarityTE (TM) Regenerates Full-Thickness Hair-Bearing Skin in Burns and Wounds Using Their Revolutionary Platform Technology. First ever known successful regeneration of full-thickness skin and hair; Company poised to initiate human trial in the third quarter of 2017; Management to host conference call Thursday, June 8th at 4:30pm ET.
Salt Lake City, UT — (Marketwired) — 06/08/17 — PolarityTE™, Inc. (NASDAQ: COOL) today announced pre-clinical results demonstrating that the Company’s lead product, SkinTE™, regenerated full-thickness, organized skin and hair follicles in third degree burn wounds. The findings represent the first known successful regeneration of skin and hair in full-thickness swine wound models, the standard animal model for human skin. The Company expects to initiate a human clinical trial evaluating the autologous homologous SkinTE™ construct in the third quarter of 2017. (more…)Read More